1. Home
  2. DTI vs LPTX Comparison

DTI vs LPTX Comparison

Compare DTI & LPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTI
  • LPTX
  • Stock Information
  • Founded
  • DTI 1984
  • LPTX 2011
  • Country
  • DTI United States
  • LPTX United States
  • Employees
  • DTI N/A
  • LPTX N/A
  • Industry
  • DTI Metal Fabrications
  • LPTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DTI Industrials
  • LPTX Health Care
  • Exchange
  • DTI Nasdaq
  • LPTX Nasdaq
  • Market Cap
  • DTI 118.5M
  • LPTX 119.6M
  • IPO Year
  • DTI N/A
  • LPTX N/A
  • Fundamental
  • Price
  • DTI $2.48
  • LPTX $0.31
  • Analyst Decision
  • DTI Strong Buy
  • LPTX Buy
  • Analyst Count
  • DTI 1
  • LPTX 2
  • Target Price
  • DTI $5.50
  • LPTX $8.00
  • AVG Volume (30 Days)
  • DTI 63.6K
  • LPTX 5.8M
  • Earning Date
  • DTI 03-13-2025
  • LPTX 03-26-2025
  • Dividend Yield
  • DTI N/A
  • LPTX N/A
  • EPS Growth
  • DTI N/A
  • LPTX N/A
  • EPS
  • DTI 0.09
  • LPTX N/A
  • Revenue
  • DTI $154,446,000.00
  • LPTX N/A
  • Revenue This Year
  • DTI $10.54
  • LPTX N/A
  • Revenue Next Year
  • DTI $6.87
  • LPTX N/A
  • P/E Ratio
  • DTI $26.60
  • LPTX N/A
  • Revenue Growth
  • DTI 1.59
  • LPTX N/A
  • 52 Week Low
  • DTI $2.37
  • LPTX $0.28
  • 52 Week High
  • DTI $6.36
  • LPTX $4.79
  • Technical
  • Relative Strength Index (RSI)
  • DTI 33.12
  • LPTX 25.59
  • Support Level
  • DTI $2.69
  • LPTX $0.41
  • Resistance Level
  • DTI $2.76
  • LPTX $0.65
  • Average True Range (ATR)
  • DTI 0.16
  • LPTX 0.05
  • MACD
  • DTI -0.01
  • LPTX 0.03
  • Stochastic Oscillator
  • DTI 0.00
  • LPTX 6.78

About DTI Drilling Tools International Corporation

Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The Company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The Company's international operations are located in Canada with additional stocking points in Europe and the Middle East.

About LPTX Leap Therapeutics Inc.

Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .

Share on Social Networks: